1. Home
  2. SMG vs IOVA Comparison

SMG vs IOVA Comparison

Compare SMG & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scotts Miracle-Gro Company (The)

SMG

Scotts Miracle-Gro Company (The)

HOLD

Current Price

$64.69

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.73

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMG
IOVA
Founded
1868
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
1.5B
IPO Year
2012
2008

Fundamental Metrics

Financial Performance
Metric
SMG
IOVA
Price
$64.69
$3.73
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$73.00
$9.00
AVG Volume (30 Days)
908.3K
12.8M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.97%
N/A
EPS Growth
504.92
14.84
EPS
N/A
N/A
Revenue
$3,016,500,000.00
N/A
Revenue This Year
N/A
$47.74
Revenue Next Year
$2.63
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
6.17
N/A
52 Week Low
$45.61
$1.64
52 Week High
$72.35
$5.63

Technical Indicators

Market Signals
Indicator
SMG
IOVA
Relative Strength Index (RSI) 51.93 50.65
Support Level $58.74 $2.02
Resistance Level $65.38 $4.33
Average True Range (ATR) 2.74 0.29
MACD 0.47 0.02
Stochastic Oscillator 64.01 46.37

Price Performance

Historical Comparison
SMG
IOVA

About SMG Scotts Miracle-Gro Company (The)

Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: